[Diagnosis and treatment of osteoporosis in nonmetastatic breast cancer]

Pia A Eiken; Mogens Hansen; Bent Kristensen; Bente L Langdahl; Bo Abrahamsen

[Diagnosis and treatment of osteoporosis in nonmetastatic breast cancer]

Ugeskr Laeger. 2011 Feb 21;173(8):577-81.

[Article in Danish]

Authors

Pia A Eiken¹, Mogens Hansen, Bent Kristensen, Bente L Langdahl, Bo Abrahamsen

Affiliation

¹ Kardiologisk-endokrinologisk Afdeling H, Hillerød Sygehus, 3400 Hillerød, Denmark. piei@hih.regionh.dk

PMID: 21333258

Abstract

The prevention of cancer-treatment-induced bone loss due to chemotherapy and long-term adjuvant breast cancer therapy has a high priority. We present an algorithm for the prevention and treatment of osteoporosis during treatment of nonmetastatic breast cancer.

Publication types

English Abstract

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Bone Density Conservation Agents / administration & dosage
Bone Density Conservation Agents / therapeutic use
Breast Neoplasms / drug therapy*
Diphosphonates / administration & dosage
Diphosphonates / therapeutic use
Female
Glucocorticoids / administration & dosage
Glucocorticoids / adverse effects
Humans
Osteoporosis* / chemically induced
Osteoporosis* / diagnosis
Osteoporosis* / drug therapy
Osteoporosis* / prevention & control
Osteoporotic Fractures / chemically induced
Osteoporotic Fractures / prevention & control
Practice Guidelines as Topic
Prednisolone / administration & dosage
Prednisolone / adverse effects
Risk Factors

Substances

Antineoplastic Agents
Bone Density Conservation Agents
Diphosphonates
Glucocorticoids
Prednisolone